NANAIMO, British Columbia --Nov. 13, 2018-- Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY), a global leader in cannabis production and distribution, today reported financial results for the third quarter and nine months ended September 30, 2018. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
“The cannabis industry remains very robust and we are pleased with our revenue momentum and strategic achievements in the third quarter,” said Brendan Kennedy, President and Chief Executive Officer of Tilray. “We are in the early stages of achieving our growth potential and our team continues to strategically execute on disciplined operational initiatives and investments to support Tilray’s long-term, sustainable growth as the pace of legalization continues to accelerate around the world. Going forward, the demand for our products is strong and we remain committed to expanding our leadership in the global medical and adult-use cannabis markets.” Third Quarter 2018 Financial Highlights
Business Highlights Global expansion of medical business and participation in clinical trials:
Adult-use Business Developments, which occurred in advance of legalization in Canada in October:
Subsequent Events
Source: Tilray Inc.
0 Comments
Leave a Reply. |
Archives
November 2019
Categories |